Cost-effectiveness analysis of roadmap models in chronic hepatitis B using tenofovir as the rescue therapy
Background: The roadmap approach is recommended to guide chronic hepatitis B treatment. We evaluated the cost-effectiveness of various treatment strategies in the global market. Methods: Lamivudine and telbivudine were tested in roadmap models with switch-to tenofovir if HBV was detectable at week 2...
Saved in:
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Published: |
International Medical Press
2010
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/15321/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|